Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/29555
Title: | Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia |
Authors: | Nesr, G Claudiani, S Milojkovic, D Innes, A Fernando, F Caballes, I Mungozi, P Szydlo, R Lovato, S Jayasena, C Apperley, J |
Keywords: | Chronic myeloid leukemia;tyrosine kinase inhibitors;fertility;semen analysis |
Issue Date: | 23-Apr-2024 |
Publisher: | Taylor and Francis |
Citation: | Nesr, G. et al. (2024) 'Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia',Leukemia & Lymphoma, 65 (8), pp. 1161 - 1166. doi: 10.1080/10428194.2024.2343758. |
Abstract: | Advancements in the management of patients with chronic myeloid leukemia (CML) allowed them to achieve survival comparable with their healthy counterparts. Consequently, their care has widened with growing focus on quality of life, including parenting children. Although tyrosine kinase inhibitors (TKI) are contraindicated in pregnancy given their teratogenic effect, their effect on male fertility is less clear with contradictory results from animal studies and case reports/series. We compared the sperm analysis parameters, as the gold-standard assessment for male fertility, of 11 patients with CP- CML before and after TKI therapy. Median therapy duration was 5.1 years (range: 2.5–16.5). The sperm concentration, % progressive, and total motility before and after therapy were not significantly different (p = 0.376, 0.569, and 0.595, respectively). Our results suggest no impairment in fertility potential in male patients after TKI therapy. A larger sample size is crucial to support/refute our findings. |
Description: | Supplemental material is available online at: https://www.tandfonline.com/doi/full/10.1080/10428194.2024.2343758#supplemental-material-section . |
URI: | https://bura.brunel.ac.uk/handle/2438/29555 |
DOI: | https://doi.org/10.1080/10428194.2024.2343758 |
ISSN: | 1042-8194 |
Other Identifiers: | ORCiD: Silvia Lovato https://orcid.org/0000-0002-1007-2556 ORCiD: George Nesr https://orcid.org/0000-0001-7147-843X |
Appears in Collections: | Dept of Health Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | Copyright © 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. | 4.07 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License